"Hemoblastoses in children"
About This Course
On-line course "Hemoblastosis in children. Independent work »using the EDX platform allows students - foreign citizens to acquire modern ideas about the epidemiology, etiology and pathogenesis of leukemia in children, modern morphological and immunological classification, marker chromosomal abnormalities, clinical manifestations of acute lymphoma diagnosis and treatment. The course allows you to understand the complications of chemotherapy in leukemia in children, to master modern ideas about the epidemiology, pathogenesis and clinical manifestations of Hodgkin's disease in children, the stage of development of the disease and the principles of chemotherapy..
The purpose of the course is to master the subjects of independent work in the discipline of Pediatrics online using the EDX platform.
Hemoblastoses in children: etiological factors of development, FAB classification of leukemia in children, immunological classification of leukemia in children, risk factors, epidemiology of acute leukemia in children, morphological features of ballast cells, chromosomal aberrations in acute leukemia in children, acute leukemia in children acute lymphoblastic and chronic non-lymphoblastic leukemia in children, clinical and laboratory diagnosis of leukemia in children, neuroleukemia, principles of treatment of acute leukemia in children, BFM protocols, complications chemotherapy, tumor lysis syndrome. Etiology and pathogenesis. Epidemiology, FAB classification, risk factors, classification, histological variants, morphological characteristics, stages of development of Hodgkin's lymphoma, clinical and laboratory diagnostics, radiological manifestations of the disease, principles of treatment
Frequently Asked Questions
What web browser should I use?
The Open edX platform works best with current versions of Chrome, Firefox or Safari, or with Internet Explorer version 9 and above.
See our list of supported browsers for the most up-to-date information.
Your answer would be displayed here.